Investigational New Drugs · 2019 · 31 citations · 31 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMedical OncologyAntineoplastic Drug ClassesCombination ChemotherapyMalignant NeoplasmsOncology PharmacologyPharmacodynamics Of Anticancer AgentsTumor BiologyAnticancer ChemotherapyAntimetabolite CombinationsBh3 Mimetic CompoundsPhase I Oncology TrialsTargeted Combination Chemotherapy
31
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
J Oan H. S Chiller, D Avid H Arrington, C Handra P. B Elani et al. · 2002 · 3.7K citations
Medicine, Oncology, Pharmacology +11
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Christin Tse, Alexander R. Shoemaker, Jessica Adickes et al. · Cancer Research · 2008 · 2K citations · Full text
Medicine, Oncology, Pharmacology +16
Taxol induces bcl-2 phosphorylation and death of prostate cancer cells.
Subrata Haldar, Janaki Chintapalli, C M Croce · PubMed · 1996 · 662 citations
Medicine, Oncology, Pharmacology +13